Reverse shoulder arthroplasty (RSA) has been established as an effective primary and salvage treatment option for complex disorders of the shoulder that had previously been extremely difficult to treat^[@R1]-[@R4]^. RSA was initially utilized to treat rotator cuff tear arthropathy and unreconstructible massive rotator cuff tears. Secure fixation to the scapula without cement has been of interest to surgeons faced with severe glenoid bone deficiency. If the amount of native bone available for contact between the scapula and the underside of the baseplate is inadequate, allograft or autograft bone must be used to provide structural support and, if necessary, assist in lateralization of the baseplate. The results of bone-grafting for focal glenoid deficiency in anatomic total shoulder arthroplasty (TSA) have been poor because of graft subsidence and resorption^[@R5],[@R6]^. The results of RSA when performed as a revision surgery, sometimes with the use of bone graft, are known to be inferior to those of primary RSA^[@R7]-[@R14]^. However, little is known about the results of primary RSA when bone graft is utilized for severe focal glenoid deficiency.

We performed a retrospective review of the functional outcomes for our patients following primary RSA with utilization of allograft or autograft bone to supplement a deficient glenoid. Additionally, the degree of bone loss was evaluated using a 2-dimensional/3-dimensional (2D-3D) image registration of preoperative computed tomography (CT) scans and postoperative radiographs. We hypothesized that outcomes of RSA would be positively correlated with the amount of native bone support under the glenoid baseplate at the time of implantation.

Materials and Methods {#s1}
=====================

Study Subjects {#s1-1}
--------------

This study was determined to be exempt from review by the Western Institutional Review Board. We identified all patients who had undergone primary RSA with the use of bone-grafting for glenoid deficiency between January 2004 and August 2012. A group of 38 patients (40 shoulders) with \<2 years of follow-up was excluded. The study group consisted of 57 consecutive patients (mean age and standard deviation, 73 ± 8 years) with minimum 2-year outcome data (mean, 46 months; range, 24 to 105 months) who underwent primary RSA in the setting of substantial glenoid bone loss (Table I). Chart review was performed to identify the diagnosis and surgical indication for each patient. Surgery was performed for an underlying diagnosis of rotator cuff tear arthropathy in 38 shoulders (67%), rheumatoid arthritis in 9 shoulders (16%), osteoarthritis in 7 shoulders (12%), and chronic dislocation in 3 shoulders (5%). In 19 shoulders (33%), the rotator cuff was intact. Patients demonstrated severe glenoid bone loss, which was identified using the preoperative CT scan to apply the most suitable classification system, on the basis of the underlying diagnosis and bone loss pattern. Sixteen glenoids were classified as grade E1 and 19 glenoids, as grade E3, according to the Sirveaux classification^[@R15]^; 9 glenoids, as grade 3, according to the Levigne classification^[@R3]^; 3 glenoids, as type A2, 2, as type B2, and 2, as type C, according to the Walch classification^[@R16]^; and 6 glenoids with severe bone loss were unable to be classified using published classification criteria (Table II).
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Demographics of Study Group
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Study Group Rotator Cuff Status and Bone Loss Grading
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Clinical Outcomes {#s1-2}
-----------------

Patients had follow-up evaluations at 1 week, 6 weeks, 3 months, 6 months, 1 year, and annually thereafter, and the American Shoulder and Elbow Surgeons (ASES) score, Simple Shoulder Test (SST), 10-point visual analog scale (VAS) scores for pain and function, and patient satisfaction rating were collected and assessed at a minimum of 2 years (mean, 46 months) from the date of surgery for comparison with preoperative values^[@R17],[@R18]^. Patient satisfaction was determined on a 10-point scale, with a score of 1 indicating the lowest satisfaction and a score of 10, the highest satisfaction. Active range-of-motion measurements were reported, and these were collected preoperatively and postoperatively using a previously described video method^[@R19]^. We assessed the postoperative radiographs (anteroposterior, Grashey, scapular Y, and axillary lateral) of each patient at the latest follow-up (mean, 46 months) for evidence of hardware failure; radiolucent lines, indicating loosening; scapular fracture; and bone-graft incorporation. The use of either the conventional or alternative centerline was evaluated on immediate postoperative radiographs for every patient. Complications were identified by both chart and radiographic reviews. Major complications were defined as those resulting in hospital readmission within 90 days of surgery, any readmission requiring further surgery to the shoulder or arm, and any periprosthetic fracture or implant failure that underwent nonoperative treatment because of either patient or surgeon preference.

Surgical Technique {#s1-3}
------------------

The senior author (M.A.F.) performed all surgeries using a standard deltopectoral approach. Intraoperatively, in no case was the acceptable threshold percentage (80%) of contact achieved between the glenoid baseplate (Reverse Shoulder Prosthesis; DJO Surgical) and the host bone. For this reason, the glenoid baseplate was implanted with bone-graft augmentation using the surgical technique previously described by Klein et al.^[@R1]^. Selection of graft material was based on intraoperative availability (Fig. [1](#F1){ref-type="fig"}). Autograft (52 patients; 91%) was preferentially used when adequate bone could be salvaged from the humeral head, often after humeral head osteotomy (Fig. [2](#F2){ref-type="fig"}). When allograft (5 patients; 9%) was required because of insufficient or poor-quality autograft bone, a femoral head allograft was used. Glenosphere size was determined on the basis of the soft-tissue tension. The 36-mm and 40-mm glenosphere sizes (in 40 and 5 patients, respectively) offered a hooded design and could increase contact surface area of the glenosphere with the native scapula, and in many cases this design feature was utilized during surgery. However, 32-mm glenospheres (in 12 patients) were used at the discretion of the senior author in the instances in which it best fit the patient's anatomy.

![**Figs. 1-A through 1-D** Illustrative steps in graft placement and technique. **Fig. 1-A** A Sawbones graft (Pacific Research Laboratories) shaped to fit the defect with a tap inserted through the graft. **Fig. 1-B** Intraoperative image of a provisionally pinned humeral head autograft with a screw-in baseplate being inserted to compress the graft into the defect. **Fig. 1-C** Uncontained defect with a hooded glenosphere oriented to make contact with the graft and load-share with the baseplate. **Fig. 1-D** Intraoperative image after completed grafting of an uncontained defect and glenosphere contact with the posterior part of the graft.](jbjsoa-2-e0015-g003){#F1}

![**Figs. 2-A and 2-B** A patient who had primary cuff tear arthropathy with substantial superior bone loss. **Fig. 2-A** Preoperative radiograph. **Fig. 2-B** Radiograph made 8 years postoperatively showing full incorporation of superior autograft from humeral head.](jbjsoa-2-e0015-g004){#F2}

2D-3D Registration {#s1-4}
------------------

Image registration for the assessment of native bone support was performed using 3D reconstruction of preoperative CT scan data in combination with postoperative radiographs made 3 months following surgery. Postoperative CT scans were not made, as they are not routinely used in the senior author's practice. Additionally, the goal of the study was to correlate function with the amount of native bone support at the time of implantation irrespective of the amount of bone-graft incorporation over time. The ASES score was used as the surrogate for function in an attempt to correlate native bone support with function. Sizing information for the baseplate and glenosphere was taken from the hospital record, and virtual models of the implants (baseplate and glenosphere) were then created and used for virtual implantation in Mimics 17 (Materialise). The exact position of the implant with respect to the 3D scapular model was determined using contour projection shape-mapping algorithms present in the software, which performs 2D-3D image registration using virtual x-ray emitters in a best-fit shape-matching algorithm as a virtual model is rotated to exactly match the silhouette created by the model on radiographs (Figs. [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). This shape-matching algorithm has been found to replicate the spatial relationships between anatomy and prosthesis within a mean of 0.60 ± 0.52 mm and 1.15° ± 0.87°^[@R20]^. The acromion was used as a reference, since its shape is not altered by the RSA procedure. However, when the acromion was poorly visualized or fractured, postoperative radiographs were considered inadequate, and these patients were excluded. A total of 6 patients were excluded because of inadequate CT format, and an additional 7 patients were excluded because of the abovementioned problems with a poorly visualized or fractured acromion on postoperative radiographs. This left 44 patients who had both preoperative CT scans and adequate postoperative radiographs to be included in this arm of the study. The resulting 3D position of the surgical implant relative to the scapula was then imported into a software program, 3-matic (Materialise), which allowed us to calculate the contact area of the implant (baseplate and glenosphere) that intersected with the host bone (Fig. [5](#F5){ref-type="fig"}). This area was normalized as a function of total available surface area and was reported as a percentage.

![A simplified example of the virtual emitter system. The light source (left) creates a shadow projection of a virtual model onto a surface (right). Similar to a shadow, the projection is dependent on the location of the model and background relative to the light source. The shadow's outline is representative of the contours that will be fitted.](jbjsoa-2-e0015-g005){#F3}

![An example of the virtual workspace. The projected contours are fitted to the user-defined contours, utilizing the 3D models and postoperative radiograph.](jbjsoa-2-e0015-g006){#F4}

![**Figs. 5-A, 5-B, and 5-C** An example of the software program, 3-matic (Materialise), that was used to calculate the contact area of the implant (baseplate and glenosphere) that intersected with the host bone. **Fig. 5-A** The final positioning of the implant on the scapula with a gap between the glenosphere and the host bone. **Fig. 5-B** The translucent model displays the anterior host bone contact. **Fig. 5-C** A 2D representation of the intersecting area between the host bone and the baseplate.](jbjsoa-2-e0015-g007){#F5}

Application of the registration method applied to the shoulder joint has been validated using a cadaveric model. A fresh-frozen cadaveric shoulder was thawed overnight, and the scapula was disarticulated and dissected of all soft tissues. A CT scan of the scapula was made following parameters identical to those for clinical scans. The senior author created a bone loss model and performed baseplate implantation (Fig. [6](#F6){ref-type="fig"}). Subsequently, a set of 3 planar radiographs was made. The 2D-3D registration was performed following the methodology described above (Fig. [7](#F7){ref-type="fig"}). Lastly, the contact area at the baseplate-host bone interface was estimated in the cadaveric model. The baseplate was carefully displaced, and the contact area of the baseplate was covered with a thin layer of acrylic paint and carefully implanted back. After baseplate removal, the area of the glenoid covered with paint was evaluated using digital photography (Fig. [8](#F8){ref-type="fig"}).

![Bone loss model (left) and the implanted baseplate in the glenoid bone loss model (right).](jbjsoa-2-e0015-g008){#F6}

![**Figs. 7-A through 7-D** Comparison of the cadaveric model and the computer model in 4 views. **Fig. 7-A** Anteroposterior view. **Fig. 7-B** Posteroanterior view. **Fig. 7-C** Lateral view. **Fig. 7-D** Grashey view.](jbjsoa-2-e0015-g009){#F7}

![Estimation of the glenoid-baseplate interface area in the cadaveric model, showing the 2D-3D registration-based area estimation (left), cadaveric model (center), and still picture estimation of the area using image analysis (2D estimation) (right). CAD = computer-aided design.](jbjsoa-2-e0015-g010){#F8}

Statistical Analysis {#s1-5}
--------------------

The normality of all parameters was evaluated (Shapiro-Wilk test). A paired t test or alternative Wilcoxon signed-rank test was used to evaluate outcome measures. Pearson correlation analysis was performed for continuous variables. A p value of \<0.05 was considered significant for all tests, with analyses performed with SPSS software (version 22; IBM).

Results {#s2}
=======

Overall, the patients with functional outcome measures demonstrated significant improvement from preoperative values (Table III). Patient satisfaction in the study group averaged 8.6 ± 1.8 of a possible 10 points. In 56 cases (98%), the graft was fully incorporated. There were 4 major complications (7%) in the study group, and none of them involved glenoid baseplate failure. One baseplate demonstrated radiolucent lines concerning for loosening; however, the patient did not show signs of clinical failure and therefore did not undergo revision surgery (Grade 4 according to Deutsch et al.^[@R21]^). Complications required revision surgery in 3 patients. Two shoulders underwent a single-stage revision to a long-stemmed implant for humeral loosening, and 1 was treated with open reduction and internal fixation for a periprosthetic fracture. There were 5 acromial or scapular spine fractures (9%) noted in the study group. Four patients (7%) demonstrated scapular notching; 3 had grade 1 and 1 had grade 3, according to the system described by Sirveaux et al.^[@R15]^.

###### 

Preoperative and Postoperative Clinical Outcome Scores and Range of Motion of Primary RSA with Bone Graft
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Software-reported shape-matching of the prosthesis within our study between projected and generated contours of implants was found to be ≥90%. The mean percentage of the implant (baseplate and glenosphere) supported by native bone was 17% ± 12% (range, 0% to 50%). There was no significant association between host bone coverage and the change in the ASES score (p = 0.51).

Validation of the registration method revealed a good match between computer-based (413.92 mm^2^) and cadaveric-based (397.16 mm^2^) estimation of the contact area (Fig. [8](#F8){ref-type="fig"}).

Discussion {#s3}
==========

Reverse shoulder arthroplasty has become a valuable tool available to shoulder surgeons who treat complex pathology, and in many cases, including primary arthroplasties, the surgeon may encounter severe glenoid bone loss. Most studies of RSA in the setting of glenoid bone loss have focused on revision arthroplasty, and relatively little is known about the results of primary RSA when structural bone graft is needed to restore eroded glenoid bone stock. The results of our study indicate that the use of structural bone graft in primary RSA produces good outcomes that are comparable with outcomes of RSA performed without bone-grafting, and that outcomes are not dependent on the amount of host bone available to provide support under the baseplate^[@R22],[@R23]^.

This study represents what we believe is the largest reported series of primary RSAs performed with glenoid bone-grafting for severe glenoid deficiency, and the outcomes in our study group were equivalent to or better than those previously reported^[@R8],[@R23],[@R24]^. Neyton et al. reported a series of 9 patients who underwent RSA with glenoid bone-grafting and showed improvement in the pain score and no baseplate loosening; however, poor functional outcomes were reported after 2 years^[@R25]^. Levigne et al. studied primary RSA with bone-grafting in 34 patients and found a bone-graft incorporation rate of 72.9%, with improvement in the Constant score and otherwise variable functional outcomes^[@R3]^. However, more recently, Jones et al., in a study evaluating a combined cohort of patients managed with primary and revision RSA who underwent structural glenoid grafting, reported improved functional outcomes similar to those in our patients at the latest follow-up^[@R23]^. The current study notes a 98% rate of bone-graft incorporation. The reason for the difference in the outcomes that we report in this series may be related to the substantial experience of the senior author in using RSA to treat a variety of severe pathologies of the shoulder as well as the superior compressive force provided by the implant^[@R24]^. The use of a fixed-angle central screw provides for immediate stable fixation by compression of the undersurface of the baseplate against available osseous contact. Proprioception of the increased torque as the undersurface of the baseplate compresses against the osseous contact provides the surgeon immediate feedback on the security of fixation.

Many surgeons now use RSA to treat complex pathology of the shoulder, and use of the device is increasing^[@R26]^. Most reports of RSA with bone-grafting have described surgery performed in the revision setting, and it is understood that outcomes of revision surgery are generally poorer and therefore patient and surgeon expectations would be expected to be different^[@R13],[@R25],[@R27]-[@R29]^. In a large series of revision RSAs performed with bone-grafting (40 patients), Wagner et al. reported that implant survival at 2 and 5 years was 88% and 76%, respectively^[@R27],[@R28]^. Those authors noted particular concern when a lateralized RSA was implanted, although this effect did not reach significance. The patients in our study all underwent primary RSA with a lateralized glenoid component, and we observed no baseplate failures, with 1 patient at risk of loosening because of radiolucent lines around the baseplate. The amount of host contact between the baseplate and the native glenoid was on average 17%, suggesting that a bone graft to restore a large majority of the glenoid surface was necessary to provide complete coverage of the baseplate. Additionally, Formaini et al. evaluated our screw-in baseplate design biomechanically and determined that a minimum of 50% bone support was necessary at implantation to keep micromotion below the threshold level to allow for bone ingrowth to support the baseplate^[@R30]^. Our method of measuring the actual postoperative placement of the baseplate by utilizing standardized 2D radiographs and then the preoperative 3D glenoid image to determine the degree of contact with the baseplate provides a method to evaluate implant position after surgical implantation. Despite having a large portion of the implant resting on bone graft in patients with severe glenoid deficiency, there were no glenoid-sided failures.

It is important to differentiate our results from those of osseous increased-offset RSAs (BIO-RSAs; Tornier), in which structural bone graft is used to provide increased lateral offset to the glenosphere^[@R31],[@R32]^. Bone-grafting for patients in the present study was performed for severe bone loss or deformity that would have otherwise resulted in a lack of support for the glenoid baseplate. The favorable outcomes demonstrated in this cohort could not, in our estimation, have been achieved without the use of structural bone graft. The improvement in all motion parameters, including internal and external rotation, and the low rate of scapular notching also provide evidence that patients with severe glenoid bone loss can anticipate a reliable surgical outcome, with improvement of function and a reduction of pain at an average of 46 months with stable implant interfaces.

Weaknesses of this study relate to its retrospective nature, and to the theoretical limitations imposed by the use of modeling software. We also do not routinely make postoperative CT scans to assess for bone graft incorporation, and therefore it is unknown whether this is a factor that influences outcome. However, no baseplate failures were observed in our study cohort, and most patients were greatly improved following surgery to restore function that had been lost because of a severely deformed shoulder.

In conclusion, we found good outcomes in a series of 57 patients who had primary RSA with bone graft augmentation for severe glenoid bone loss. Functional outcome was not related to the degree of native bone support under the glenoid baseplate, making bone-grafting an attractive option in even the most challenging shoulder arthroplasty cases. However, it is important to note that our study population consisted of patients with a great variation in the types of glenoid bone loss, and our analysis was not sufficiently powered to evaluate this variation. To our knowledge, the present study is the largest reported series of patients undergoing primary RSA with bone-grafting for severe glenoid bone deficiency. On the basis of the results reported in this series, we continue to perform primary RSA with bone graft augmentation for severe glenoid bone loss, and we counsel patients that outcomes can be excellent despite their severe glenoid bone loss.
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